Healthcare and Life Science
Meet Cambridge helps to bring international neurotrauma conference to the city
The official bureau for conferences and events in Cambridge and the surrounding area is seeing the culmination of five years’ preparation as partner to the organising committee for one of the world’s largest medical conferences in its field. ...
Natural probiotic discovered in UK newborns' microbiomes
Newborn babies have one of three pioneer bacteria in their gut shortly after birth, one of which could be used to develop new personalised infant therapeutic probiotics, researchers show. ...
Newcells Biotech launches Lung Ciliary Beat Frequency assay to enhance safety and efficacy profiling in preclinical drug development
Application of new CiliaBeat software to provide reliable and predictive data on the impact of drugs on cilia function Assay leverages Newcells’ complex lung small airway in vitro model to enable highly sensitive assessment of drug efficacy and chemical safety as part of expanded se...
CMR Surgical strengthens senior team
CMR Surgical, the global surgical robotics business, announces the appointment of Markus Bauman as Chief Legal & Business Affairs Officer, joining the Company’s executive leadership team. ...
Qkine expands senior leadership
Qkine expands senior leadership with the appointment of Rob Nixon, Commercial Director, and Paul Grafham, Chief Financial Officer. ...
ARU vision research shortlisted for national awards
Anglia Ruskin University nominated in two categories by Times Higher Education.
Overcoming obstacles in medical device innovation
Co-authored by Samantha Shelley, SQMS
Unlocking opportunities in China's thriving Life Sciences market
As the second-largest healthcare market in the world, China is on an extraordinary trajectory of growth, with its life sciences sector expected to triple in size by 2030. This is an exciting time for UK life science companies looking to expand their horizons. Excellence First Enterprise...
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Partnership provides Medicines Discovery Catapult access to CRISPR gene editing technology across a broad range of drug discovery applications Dublin, Ireland, and Cheshire, UK: ERS Genomics Limited, the CRISPR licensing Company, and Medicines Discovery Catapult, an independent, not...
From farms to factories: patient journey to Pulmonary Fibrosis
Rosemary’s health journey has been anything but straightforward. After enduring three years of painful breathing tests with countless visits to her GP and specialist consultants, she was finally given a diagnosis 12 months later—a name that escaped her when her granddaughter asked. Havi...